Latest news

Researchers discover new target recognised by T cells involved in gut immunosurveillance

Researchers discover new target recognised by T cells involved in gut immunosurveillance
Description
Researchers in the University of Birmingham's Institute of Immunology and Immunotherapy have discovered a new target recognised by local T-cells involved in immunosurveillance in the gut.
Date:
19/11/2019

BSI Tumour Immunology Group

Description
Professor Ben Willcox from the University of Birmingham's Institute of Immunology and Immunotherapy writes for the British Society of Immunology on the UK-wide Tumour Immunology Group.
Date:
19/11/2019

Experts to gather in Africa to speed up development of vaccines to prevent bacterial infections

Experts to gather in Africa to speed up development of vaccines to prevent bacterial infections
Description
A global network of scientists who are working together to accelerate the development of vaccines against bacterial infections in low and middle income countries are to stage an annual network meeting in Africa.
Date:
11/11/2019

New collaborative learning hub helps bridge the gap between medicine and engineering

New collaborative learning hub helps bridge the gap between medicine and engineering
Description
The Clinician Engineer Hub aims to educate medical students and early career doctors about the diagnostic and treatment challenges in clinical medicine.
Date:
30/10/2019

Senior Clinical Lecturer joins Institute of Immunology and Immunotherapy

Senior Clinical Lecturer joins Institute of Immunology and Immunotherapy
Description
Dr Leila Khoja joins Birmingham from AstraZeneca and Addenbrooke's Hospital, bringing with her an extensive experience in translating immunotherapies from bench to bedside.
Date:
29/10/2019

Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation

Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation
Description
Researchers at the University of Birmingham awarded £1.15 million for latest equipment for immune regulation.
Date:
25/10/2019

New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease

New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease
Description
A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
Date:
03/10/2019

Removing cancer's protective barrier could boost immunotherapy treatments

Removing cancer's protective barrier could boost immunotherapy treatments
Description
University of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.
Date:
27/08/2019

Award success for the College of Medical and Dental Sciences at the University of Birmingham's Founders' Awards

Award success for the College of Medical and Dental Sciences at the University of Birmingham's Founders' Awards
Description
The College of Medical and Dental Sciences is delighted to announce that at the University's Awards for Excellence 2019 colleagues from across the College were awarded three of the evening's five awards.
Date:
19/07/2019

Crohn's & Colitis UK fund new Birmingham research into an app to monitor patient health

Description
Professor Subrata Ghosh has been awarded new funding to study the IBD Disk – an app for people to monitor Crohn's or Colitis and share their findings with health professionals.
Date:
16/07/2019
Displaying 1 to 10 of 75
Previous 1 2 3 4 5 Next